Gastrazole (JB95008), a novel CCK2/gastrin receptor antagonist, in the treatment of advanced pancreatic cancer: results from two randomised controlled trials.

Chau, I., Cunningham, D., Russell, C., Norman, A.R., Kurzawinski, T., Harper, P., Harrison, P., Middleton, G., Daniels, F., Hickish, T. F., Prendeville, J., Ross, P.J., Theis, B., Hull, R., Walker, M., Shankley, N., Kalindjian, B., Murray, G., Gillbanks, A. and Black, J., 2006. Gastrazole (JB95008), a novel CCK2/gastrin receptor antagonist, in the treatment of advanced pancreatic cancer: results from two randomised controlled trials. British Journal of Cancer, 94 (8), pp. 1107-1115.

Full text not available from this repository.

Official URL: http://www.nature.com/bjc/journal/v94/n8/abs/66030...

DOI: 10.1038/sj.bjc.6603058


Item Type:Article
ISSN:0007-0920
Subjects:Technology > Medicine and Health
Group:School of Health and Social Care > Centre for Postgraduate Medical Research and Education
ID Code:6317
Deposited By:INVALID USER
Deposited On:21 Oct 2008 21:45
Last Modified:07 Mar 2013 14:51
Repository Staff Only -
BU Staff Only -
Help Guide - Editing Your Items in BURO